Logo
    Search

    A Possible Explanation for Long COVID Gains Traction

    en-usApril 17, 2023

    Podcast Summary

    • Living with the Complexities of Long COVIDDespite affecting millions, Long COVID's causes and symptoms vary greatly, leading to challenges in diagnosis, treatment, and understanding from healthcare providers and loved ones.

      Long COVID, a condition affecting an estimated 15 million adults in the US, can have debilitating and lingering health effects that vary greatly in severity and duration. Shelby Hedgecock, a former personal trainer, shared her experience of struggling with long COVID symptoms, including brain fog and the need for constant medical attention, after contracting COVID-19. The causes and reasons why some people develop long COVID while others don't are not yet fully understood. The condition can be quite debilitating, with symptoms linked to over 200 different health issues, and many patients face challenges in getting their condition recognized and treated by healthcare providers and loved ones. The severity and impact of long COVID can range from slow recovery to debilitating and long-lasting health issues, making it a complex and multifaceted condition that requires ongoing attention and support.

    • Understanding Long COVID: Researchers Focus on Immune System's RoleResearchers are discovering high levels of virus-targeted immune cells in individuals with long COVID, potentially leading to new treatments or cures. However, concern exists that funding and resources for research may decrease as the focus shifts away from the pandemic.

      While the federal government is ending the public health emergency in May and the country is making progress in its COVID-19 recovery, some individuals continue to struggle with long-term effects of the virus. Researchers like Brent Palmer at the University of Colorado are working diligently to understand the underlying causes of long COVID, specifically focusing on the immune system's response to the virus. One intriguing finding is the presence of high levels of virus-targeted immune cells, known as T cells, in the blood of individuals with lingering symptoms. Palmer and others in the scientific community are hoping that this discovery could lead to new treatments or cures for long COVID. However, there is a concern that as politicians and the media shift their focus away from the pandemic, funding and resources for research may dwindle, leaving those with long-term symptoms feeling overlooked and hopeless.

    • Long COVID patients may harbor hidden virusLong COVID patients exhibit higher T cell counts, systemic inflammation, and impaired lung function, with evidence of viral proteins and RNA in their blood and tissues up to a year after infection, indicating a persistent viral presence

      Researchers are finding evidence suggesting the virus may not be entirely gone in some long COVID patients, despite testing negative for the virus in nasal swabs. T cells, a type of immune cell, are present at much higher levels in long COVID patients than those without symptoms months after infection. Additionally, these patients have higher levels of systemic inflammation and worse lung function. Studies have detected viral proteins, particularly the spike protein, in the blood of some long COVID patients up to a year after infection, indicating the presence of a persistent active viral infection. Furthermore, evidence of the virus has been found in various tissues throughout the body, including the gut, stool, and major organs like the lungs, kidneys, liver, heart, and brain, in autopsy studies. These findings suggest that the virus may be hiding in viral reservoirs in the body, continuing to cause harm and potentially contributing to long-term symptoms.

    • SARS-CoV-2 virus may persist in the body for extended periods contributing to long-term COVID symptomsRecent studies suggest the virus could linger in various organs up to 200 days post-infection, potentially causing chronic inflammation and immune dysfunction, contributing to long-term COVID symptoms. Further research is needed to understand the mechanisms and implications.

      Recent studies suggest the SARS-CoV-2 virus may persist in various parts of the body for extended periods, potentially contributing to long-term COVID symptoms. Researchers have found genetic material from the virus in the brain and other organs up to 200 days after initial infection. While this research didn't specifically focus on long COVID, it provides strong biological plausibility that viral reservoirs could play a role. Scientists now need to determine if and how the virus persists differently in various body sites and explore the potential mechanisms behind long-term symptoms. For instance, the immune response to the virus or its components could lead to chronic inflammation and immune dysfunction. Further research is necessary to understand the nuances of viral persistence and its role in long COVID. Additionally, scientists are investigating other theories, such as the impact of viral reservoirs in the gut on the immune system and the potential role of autoimmunity, damaged tissue, or tiny blood clots.

    • Exploring potential causes and treatments for long COVIDLong COVID's causes are complex, and treatments like antivirals, such as Paxlovid, may help extinguish residual virus and provide a new baseline for recovery, offering hope and improved starting points.

      The causes of long COVID are not mutually exclusive, and each theory could contribute independently to the immune system's problems. Treatments like antivirals, such as Paxlovid, are gaining interest as they may help extinguish any residual virus and provide a new improved baseline for those suffering from long COVID. While the effectiveness of these treatments is still being studied, anecdotal evidence suggests they can lead to significant improvements in symptoms. For instance, Scott LaDuke, who dealt with long COVID since the pandemic's early stages, reported dramatic benefits after taking Paxlovid for 15 days, including increased energy and the ability to resume light jogging. However, the improvements did not last forever, and he eventually backslid. Nonetheless, the medication gave him renewed hope and a better starting point for his recovery.

    Recent Episodes from Consider This from NPR

    The evolution of Pride

    The evolution of Pride
    More than 50 years of Pride marches, parades, festivals, and now partnership deals with major brands has increased LGBTQ visibility and community. And as a result, it's also made Pride the target of a backlash.

    Host Scott Detrow speaks with Eric Marcus, the creator of the podcast "Making Gay History" about how Pride has evolved into what it is today.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Consider This from NPR
    en-usJune 30, 2024

    Biden tries to reassure voters after a shaky debate performance

    Biden tries to reassure voters after a shaky debate performance
    The day after a debate in which he faltered many times, President Joe Biden hit the campaign trail to try and reassure supporters that he is still up for the job and capable of beating former President Donald Trump in November.

    His performance in the CNN debate on Thursday led many Democrats to panic about his chances of winning reelection. Some commentators who have long supported Biden even called for him to step aside.

    NPR's Scott Detrow speaks with NPR Senior White House Correspondent Tamara Keith and Congressional Correspondent Deirdre Walsh about what happens next and whether Biden can quell Democrats' fears.

    For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.

    Email us at considerthis@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Consider This from NPR
    en-usJune 28, 2024

    Gun violence is getting worse. Is this the solution?

    Gun violence is getting worse. Is this the solution?
    The surgeon general's office has declared gun violence a national public health crisis.

    It's the first time the body has ever issued a public health advisory about firearms, and for Surgeon General Vivek Murthy, it's a step in reframing the conversation about death by gunfire.

    According to the CDC, more than 48,000 Americans were killed by gun violence in 2021, and over half of those deaths were by suicide.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Consider This from NPR
    en-usJune 27, 2024

    Biden's executive actions on immigration send mixed signals

    Biden's executive actions on immigration send mixed signals
    In early June, President Joe Biden severely restricted asylum requests from migrants attempting to cross the U.S.-Mexico border without authorization.

    Two weeks later, the President struck a more welcoming tone, saying he'd protect hundreds of thousands of undocumented immigrants married to U.S. citizens.

    Immigration has become a big issue, for both parties. Policy experts say Biden hopes that in a close election year, these executive actions will sway voters to his side.

    But will that strategy pay off and how will it affect migrants?

    NPR's Adrian Florido speaks with immigration correspondent Jasmine Garsd who is reporting from the San Diego border with Mexico.

    For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.

    Email us at considerthis@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Consider This from NPR
    en-usJune 23, 2024

    The U.S. election results will reverberate around the world

    The U.S. election results will reverberate around the world
    Polls – and NPR's own reporting – tell a story of many Americans fatigued by the upcoming presidential race. They're not satisfied with the choice between two men who have both already held the office of President.

    But American allies and partners are watching the race intently, including South Korea, Japan, Ukraine and Israel. The fates of those countries are closely tied to whether Donald Trump or Joe Biden ends up sitting in the White House next year.

    The NPR correspondents who cover those countries, Anthony Kuhn in South Korea, Joanna Kakissis in Ukraine, and Daniel Estrin in Israel, discuss the stakes each of those countries have in the outcome of America's presidential election.

    For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.

    Email us at considerthis@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Consider This from NPR
    en-usJune 20, 2024

    Federal student aid still up in the air for many

    Federal student aid still up in the air for many
    This year's college application process was supposed to get easier.

    That's because last year, the U.S. Department of Education announced changes to the Free Application for Federal Student Aid, or FAFSA.

    The problems with the FAFSA form began last fall.

    And with August and September around the corner, some applicants continue to experience technical issues.

    Before this year, students would already know how much aid they're getting. But in 2024, not knowing, which is the case for many, could mean they can't go to college.

    For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.

    Email us at considerthis@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Consider This from NPR
    en-usJune 19, 2024

    Related Episodes

    Long COVID Scientists Try To Unravel Blood Clot Mystery

    Long COVID Scientists Try To Unravel Blood Clot Mystery
    The COVID-19 public health emergency has ended, but millions across the globe continue to deal with Long COVID. Researchers are still pursuing basic questions about Long COVID — its causes, how to test for it and how it progresses. Today, we look at a group of researchers studying the blood of some Long COVID patients in the hopes of finding a biomarker that could let physicians test for the disease.

    Questions? Thread of scientific research you're loving? Email us at shortwave@npr.org — we'd love to hear about it!

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy

    Ihr Gesundheitsratgeber: Atemnot

    Ihr Gesundheitsratgeber: Atemnot
    Atemnot kann aus unterschiedlichsten Gründen auftreten. Die Ursache für eine sogenannte Dyspnoe zu finden, gehört zur täglichen Arbeit von Lungenfacharzt Dr. Matthias Schmalenbach. Er ist pneumologischer Chefarzt in der MEDICLIN Klinik Reichshof und erklärt in dieser Folge unter anderem, wann man zum Arzt gehen sollte und welche Ursachen hinter einer Atemnot stecken können.

    Long COVID Time Frame

    Long COVID Time Frame
    Long COVID can happen to anyone who has had COVID-19, even if the illness was mild, or they had no symptoms. UCSF Pulmonologist Dr. Lekshmi Santhosh discusses the time frame associated with long COVID. Dr. Santhosh explains that while each patient is unique there are some common symptom clusters. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37338]